ML-211

Lysophospholipase 1 (LYPLA1) is a protein palmitoyl thioesterase responsible for depalmitoylation of the oncogene HRas. Palmitoylation of such oncogenes is thought to be required for trafficking and malignant transformation, making LYPLA1 a target for downregulating oncogenic signaling. ML-211 is a carbamate-based dual inhibitor of LYPLA1 (IC50 = 17 nM) and the related LYPLA2 (IC50 = 30 nM). It can also inhibit the serine hydrolase ABHD11 with an IC50 value of 10 nM but is > 50-fold selective for LYPLA in a panel of 20 additional serine hydrolases.Formal Name: [4-(1,1-dimethylethyl)-1-piperidinyl][4-(hydroxydiphenylmethyl)-2H-1,2,3-triazol-2-yl]-methanone. CAS Number: 2205032-89-7. Molecular Formula: C25H30N4O2. Formula Weight: 418.5. Purity: >95%. Formulation: (Request formulation change), A crystalline solid. Solubility: DMF: 30 mg/ml, DMSO: 30 mg/ml, Ethanol: 10 mg/ml. lambdamax: 240 nm. SMILES: CC(C)(C)C1CCN(C(N2N=C(C(C3=CC=CC=C3)(O)C4=CC=CC=C4)C=N2)=O)CC1. InChi Code: InChI=1S/C25H30N4O2/c1-24(2,3)19-14-16-28(17-15-19)23(30)29-26-18-22(27-29)25(31,20-10-6-4-7-11-20)21-12-8-5-9-13-21/h4-13,18-19,31H,14-17H2,1-3H3. InChi Key: LPTMHNPBMQCQPG-UHFFFAOYSA-N.